{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:15:31Z","timestamp":1767374131062},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,1,20]],"date-time":"2004-01-20T00:00:00Z","timestamp":1074556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The severity of late cardiotoxicity after anthracycline treatment for childhood cancer relates mainly to the cumulative anthracycline dose received, but all dose ranges cause some cardiac dysfunction. Anthracycline administration by infusion in order to lower peak drug concentration has been used in an attempt to reduce cardiotoxicity. Cardiac performance was assessed by echocardiography in children who were relapse\u2010free survivors of treatment for acute lymphoblastic leukaemia (ALL). They received the same cumulative anthracycline dose (daunorubicin 180\u2003mg\/m<jats:sup>2<\/jats:sup>) either by bolus injection (UKALL \u00a0X protocol, <jats:italic>n<\/jats:italic>\u2003=\u200340) or by infusion (UKALL XI protocol, <jats:italic>n<\/jats:italic>\u2003=\u200371) with a follow\u2010up duration of 5\u00b73\u2003\u00b1\u20032\u00b70 and 5\u00b74\u2003\u00b1\u20031\u00b70\u2003years respectively. On analysis, both the bolus administration and infusion groups showed similar mild impairment of cardiac performance, characterized by increased left ventricular end systolic stress and impaired left ventricular function. In conclusion, subclinical abnormality of left ventricular performance was confirmed in both groups despite the relatively modest cumulative anthracycline dose received. We were unable to demonstrate an advantage of anthracycline administration by 6\u2010h infusion with respect to late cardiotoxicity at this dose.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.04803.x","type":"journal-article","created":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T23:55:52Z","timestamp":1103586952000},"page":"463-468","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Does anthracycline administration by infusion in children affect late cardiotoxicity?"],"prefix":"10.1111","volume":"124","author":[{"given":"G. A.","family":"Levitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Dorup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,1,20]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7192.1209"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.5.1444"},{"key":"e_1_2_12_4_1","first-page":"611","article-title":"Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous\u2010infusion schedules","volume":"8","author":"Berrak S.G.","year":"2001","journal-title":"Oncology Reports"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00177-3"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90164-7"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(84)80397-6"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)80282-7"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686550"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<512::AID-MPO8>3.0.CO;2-4"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03292.x"},{"key":"e_1_2_12_12_1","first-page":"431","article-title":"Liposomal anthracyclines","volume":"8","author":"Gabizon A.A.","year":"1994","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108079"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10298"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401704"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800100348"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.1991.tb01017.x"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<22::AID-MPO5>3.0.CO;2-V"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf167"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-2-133"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01544.x"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00028-7"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322602"},{"key":"e_1_2_12_24_1","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2002.20.6.1677","article-title":"Doxorubicin administration by continuous infusion is not cardioprotective: the Dana\u2010Farbar 91\u201301 Acute Lymphoblastic Leukemia protocol","volume":"20","author":"Lipshultz S.E.","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2746"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1058-9813(98)00008-3"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.545"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/cdd.1987.4.191"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90815-4"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79797-X"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900215)65:4<870::AID-CNCR2820650407>3.0.CO;2-D"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.7.1546"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.1.61"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11274"},{"key":"e_1_2_12_35_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1200\/JCO.1996.14.2.362","article-title":"Randomized trial of the cardioprotective agent ICRF\u2010187 in pediatric sarcoma patients treated with doxorubicin","volume":"114","author":"Wexler L.H.","year":"1996","journal-title":"Journal of Clinical Oncology"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.04803.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.04803.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.04803.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:35:20Z","timestamp":1697441720000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.04803.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,20]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1111\/j.1365-2141.2004.04803.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04803.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,20]]},"assertion":[{"value":"2004-01-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}